Arrhythmia & EP

heartwire News

  • Stroke Mortality Down, but Global Burden Remains High Although the global stroke mortality rate dropped substantially from 1990 to 2016, the global burden of stroke is still high, with more than 80 million stroke survivors, new data show.
  • WRAP-IT: Antibacterial Pouch Cuts Device Infections The trial provides the first randomized data supporting prophylaxis with the long-available TYRX envelope, but cost continues to be a consideration.
  • ACC 2019 AUGUSTUS Backs Apixaban 'Double Therapy' in Most AF Post-ACS, PCI The most safe and effective antithrombotic regimen may involve neither warfarin nor aspirin, suggested a trial that might allay bleeding-risk concerns in a tough-to-treat atrial fibrillation population.
  • ACC 2019 Apple Watch Helps Detect AF: Is This the Future? The first study of its kind involving more than 400,000 members of the general population used an Apple Watch to identify irregular pulse and received a mixed response from ACC delegates.


  • ACC 2019 Boom: TAVR Low-Risk Trials Usher in a New Era in Cardiology The results are impressive for transcatheter aortic valve replacement in low-surgical-risk patients, but longer-term data on durability will be crucial, notes John Mandrola, MD.
  • ACC 2019 Quick Thoughts on the Wrap-IT Trial An antibiotic-impregnated envelope casing for cardiac implantable devices may lower the risk for infection, but is it enough to justify the costs?
  • CABANA Takeaways for Catheter Ablation of AF   Now that CABANA is published, principal investigator Doug Packer talks with his Mayo colleagues about the implications for the management of patients with atrial fibrillation.
  • ACC 2019 Mandrola Previews the 2019 ACC Meeting The Apple Heart Study will hog the spotlight, but trials on TAVR in low-risk aortic stenosis are more likely to affect practice, says digital-health skeptic John Mandrola, MD. Links